| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.3 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.054 | 0.3 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |